Shield Therapeutics Share Discussion Threads

[nobbygnome] 31/7/2019 07:12

Thanks NYB. Good detail particularly about the trials.

[peachie 74] 31/7/2019 07:09

Presume it is a US based publication. It refers to its US name and the pop up sign up page is US based.

[ny boy] 31/7/2019 00:03

Nice write up here, with technical data, not sure if this is a US based publication?

[peachie 74] 30/7/2019 22:36

Other stuff to look forward to from Pro active investors....

• Further news on commercialisation progress, publication of peer-reviewed Feraccru data from H2H study


• Initiation of a paediatric study in infants over one-month, starting in the second half of 2019

• News on next steps with PT20 including outcomes of ongoing reformulation work

• News on partnering in new geographies – notably China in next 12 months

[ny boy] 30/7/2019 20:18

Nobby, difficult to know for sure, anyway onwards & upwards, with moments of gentle mugging.

[nobbygnome] 30/7/2019 17:53

Surely a sale which slowed the rise down despite all the buys at around that level

[ny boy] 30/7/2019 17:48

The 44k trade, could of triggered the afternoon rise?

[crankyman] 30/7/2019 17:18

That’s only Germany then. U.K. has limited coverage. Nothing in France, Spain or Italy. Germany has had promotion since thr Norgine deal was signed.

[kop202] 30/7/2019 16:40

For all the "buying" still finished down...was in the red most of the dayCity traders trying to keep the price under pressure imo to reduce momentum buying and maybe even get some folks to sell

[crankyman] 30/7/2019 16:16

I agree. U.K. and AOP numbers will be modest. Germany could be better. Full market access.

[1kiwi] 30/7/2019 16:12

Nobbygnome, it is merely a side dish ;)

[nobbygnome] 30/7/2019 16:10

Not quite sure why you say that. The drug is only really on sale in Germany, UK and the Scandinavian countries so the turnover number won't be large. I guess there will be some growth but I really wouldn't anticipate too much if I was you. In my experience it is much better to have realistic expectations....

[1kiwi] 30/7/2019 16:06

NY Boy, no mate. I don't think they will delay it, so due anytime now and I suspect we should have some really great results

[ny boy] 30/7/2019 15:59

Do you think they will delay the business update to include the commercialisation deal, it could be soon, as they had already short listed potential licensing partners, so I guess much of the work for a deal would already been done depending on the fda outcome?

[1kiwi] 30/7/2019 15:59

Paying over the ask now! Maybe mms don't want to sell to may cheap shares prior to the business update

[1kiwi] 30/7/2019 15:58

I think we may just get a 200p print before close folks

[ny boy] 30/7/2019 15:57

Nobby, changes all the time but did indicate buying interest, this is one, where you have to hold your core holding and stay patient and be relaxed, a reward for holding during riskier times before fda broad label approval!

[1kiwi] 30/7/2019 15:54

Fill or kill to buy folks!

[1kiwi] 30/7/2019 15:38

Business update due anytime now

[nobbygnome] 30/7/2019 15:35

?? 2vs1 on my screen

[nobbygnome] 30/7/2019 15:34

And the buys keep coming in even when they raise the offer..

[ny boy] 30/7/2019 15:33

L2 strong 4-2

[peachie 74] 30/7/2019 15:26

PT20 forgotten about

200 million annual turnover Hoped for !!

[1kiwi] 30/7/2019 15:24

There it goes 193p to buy